|

GENE THERAPY
THE STATE OF THE ART
Dr. Abdel Aziz El Bayoumi
Professor of Genetics
Dr. Khalid Al Ali
Lecturer of Genetics
Department of Biological Sciences
University of Qatar, Doha
|
|
7.2.1 Non-Viral Vectors Used in In-Vivo Applications
7.2.1.1 Calcium Phosphate
The technique involves, mixing plasmid DNA in a solution of calcium chloride, and then added
to a phosphate- buffered solution. After 20 minutes a fine precipitate forms in the
solution, and this solution is then added to the cells in culture. However, the number of
cells that take the introduced genes and express the desired gene is usually quite limited
and reaches around 10%, where in some cases its level is only less than 1%. Treating the
transfected cells with glecerol can increase the efficiency. The DNA precipitates most probably enter the cell by endocytosis (Ledley, F.D.
1995). It is common to transfer plasmid DNA into a variety of cell cultures and packaging
cell lines. The low level of transgene expression is a disadvantage of this technique, in
spite of its minimal toxicity and inexpensive.
|